Vertex Pharmaceuticals Incorporated (VRTX) Stock Price & Financial Analysis
Vertex Pharmaceuticals Incorporated Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Vertex Pharmaceuticals Incorporated
What is the current stock price for VRTX?
As of the latest trading session, VRTX stock trades at $438.71. The 52-week range is $362.50–$510.77, with a day range of $436.56–$449.62.
What is the P/E ratio for VRTX?
Vertex Pharmaceuticals Incorporated's trailing P/E ratio is 29.2, meaning investors pay $29.2 for every $1 of annual earnings. Vertex Pharmaceuticals Incorporated operates in the Healthcare sector.
Does VRTX pay dividends?
Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRTX?
Based on 17 analysts, the consensus for VRTX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of VRTX?
Vertex Pharmaceuticals Incorporated's market capitalization is $113.19B, classifying it as a large-cap company. Vertex Pharmaceuticals Incorporated operates in the Healthcare sector within the Biotechnology industry.